UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Newsroom

    Spotlight Story

    UCB opens applications for 2027 UCB Myasthenia Gravis Scholarship™

    Read more

    Press Releases

    BE BOLD: BIMZELX® (bimekizumab-bkzx) builds on superior joint responses versus SKYRIZI®…

    Read More

    UCB opens applications for 2027 UCB Myasthenia Gravis Scholarship™

    Read More

    UCB Establishes the Emmanuel Janssen Endowed Chair for the Evaluation of Medicines at Brigham and…

    Read More

    UCB announces U.S. FDA approval for ZILBRYSQ® (zilucoplan) autoinjector self-administration for…

    Read More

    UCB Launches Wear It Out, a Community-Driven Program Created For and With People Living With…

    Read More

    UCB Dedicates Site for New U.S. Biologics Manufacturing Campus in Georgia

    Read More

    UCB Stories

    Inside a PowerHouSe: Conversations, Connection & Learning at the 2026 UCB HS Summit

    Read More

    UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI®…

    Read More

    Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps

    Read More

    Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis

    Read More

    UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States

    Read More

    UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association…

    Read More

    For More Information